KLRA - CIK 0002096997
As of 2026-06-11, Kailera Therapeutics, Inc. (KLRA) has a market capitalization of $2.48 B, making it the #1952 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-06-11 | $2.48 B |
| 2026-06-10 | $2.48 B |
| 2026-05-29 | $3.02 B |
| 2026-05-28 | $2.84 B |
| 2026-05-26 | $2.71 B |
| 2026-05-25 | $2.74 B |
| 2026-05-24 | $2.74 B |
| 2026-05-22 | $2.74 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.
As of 2026-06-11, Kailera Therapeutics, Inc. (KLRA) has a market capitalization of $2.48 B, making it the #1952 most valuable US-listed company.
Kailera Therapeutics, Inc. is the #1952 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.